Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Paul Hudson
CEOPaul Hudson
Employees
84,587
Employees84,587
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
84,587
Employees84,587

SNY Key Statistics

Market cap
126.78B
Market cap126.78B
Price-Earnings ratio
12.96
Price-Earnings ratio12.96
Dividend yield
3.07%
Dividend yield3.07%
Average volume
1.94M
Average volume1.94M
High today
$52.67
High today$52.67
Low today
$51.71
Low today$51.71
Open price
$51.80
Open price$51.80
Volume
2.31M
Volume2.31M
52 Week high
$60.12
52 Week high$60.12
52 Week low
$44.62
52 Week low$44.62

Stock Snapshot

As of today, Sanofi(SNY) shares are valued at $51.92. The company's market cap stands at 126.78B, with a P/E ratio of 12.96 and a dividend yield of 3.1%.

As of 2025-11-18, Sanofi(SNY) stock has fluctuated between $51.71 and $52.67. The current price stands at $51.92, placing the stock +0.4% above today's low and -1.4% off the high.

The Sanofi(SNY)'s current trading volume is 2.31M, compared to an average daily volume of 1.94M.

In the last year, Sanofi(SNY) shares hit a 52-week high of $60.12 and a 52-week low of $44.62.

In the last year, Sanofi(SNY) shares hit a 52-week high of $60.12 and a 52-week low of $44.62.

SNY News

TipRanks 4d
Sanofi facility in France cited for quality control issues by ANSM

The inspection of the Sanofi (SNY) Pasteur facility located at 1541 avenue Marcel Merieux in Marcy-l’Etoile in France, conducted from June 16 to 20, 2025, revea...

TipRanks 7d
Perspective Therapeutics price target lowered to $13 from $14 at Oppenheimer

Oppenheimer lowered the firm’s price target on Perspective Therapeutics (CATX) to $13 from $14 and keeps an Outperform rating on the shares following the compan...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.